FrancophonIA/ELRC3.0 huggingface dataset:
English: Palladia can cause vascular dysfunction which can lead to oedema and thromboembolism, including pulmonary thromboembolism.
Danish: Palladia kan forårsage vaskulær dysfunktion, som kan medføre ødem og tromboembolisme, herunder pulmonal tromboemboli.
English: As toceranib is likely eliminated to a large extent by metabolism in the liver, the combination with other drugs capable of inducing or inhibiting liver enzymes should be used with caution.
Danish: Da toceranib formodentlig i høj grad elimineres via metabolisering i leveren, bør kombination med andre stoffer, der kan inducere eller hæmme leverenzymer, anvendes med forsigtighed.
English: Toceranib is a small molecule, multi-kinase inhibitor, that has both direct anti-tumour and antiangiogenic activity.
Danish: Toceranib er et lille molekyle, en multikinasehæmmer, som har både direkte anti-tumor-aktivitet og anti-angiogenetisk aktivitet.
English: To appropriately use the dose adjustment table it is advised that a complete blood cell count, serum chemistry panel and urinalysis be conducted prior to initiation of treatment and approximately one month after treatment is initiated; thereafter at approximately six week intervals or as determined by the veterinarian.
Danish: For at kunne anvende doseringstabellen hensigtsmæssigt anbefales det at tage et fuldt blodbillede, serumanalyse (serum chemistry panel) og urinanalyser før initiering af behandlingen, og cirka en måned efter behandlingen er initieret.
English: Treatment should continue in the case of stable disease, or partial or complete response, provided that the product is sufficiently well tolerated.
Danish: Behandlingen bør fortsætte ved stabil sygdom eller delvis eller komplet respons, forudsat at lægemidlet er tilstrækkeligt tolereret.
English: Concurrent anaemia, azotemia, hypoalbuminemia and hyperphosphatemia Discontinue treatment for 1 to 2 weeks until values have improved and albumin >2.5 g/dl, then decrease dose by 0.5 mg/kg.
Danish: Samtidig anæmi, azotæmi, hypoalbuminæmi og hyperphosphatæmi Afbryd behandlingen i 1 til 2 uger indtil værdierne er forbedrede og albumin >2,5 g/dl.
English: Pregnant women should not routinely administer Palladia, should avoid contact with faeces, urine and vomit from treated dogs and broken or moistened Palladia tablets.
Danish: Gravide kvinder bør ikke rutinemæssigt administrere Palladia og bør undgå kontakt med fæces, urin og opkast fra behandlede hunde og knækkede eller fugtige Palladia-tabletter.
English: In case of adverse events following overdose, treatment should be discontinued until resolution and then resumed at the recommended therapeutic dose level.
Danish: Ved bivirkninger som følge af en overdosis bør behandling afbrydes, indtil ophør af disse og derefter fortsættes med den anbefalede terapeutiske dosis.
English: The efficacy and safety of Palladia oral tablets for the treatment of mast cell tumours was evaluated in a randomised, placebo-controlled, double-masked, multicenter clinical field study involving 151 dogs with Patnaik grade II or III, recurrent, cutaneous mast cell tumours with/without local lymph node involvement.
Danish: Virkning og sikkerhed ved Palladia orale tabletter til behandling af mastcelletumorer blev vurderet i et randomiseret, placebo-kontrolleret, dobbeltblindet, multicenter, klinisk feltstudie, der inkluderede 151 hunde med Patniak grad II eller III, recidiverende kutane mastcelletumorer med eller uden lokale lymfeknudemetastaser.
English: There was also a significant advantage of Palladia over placebo in the secondary efficacy endpoint, time to tumour progression.
Danish: Palladia havde en signifikant fordel i forhold til placebo i det sekundære endepunkt, tid til tumorprogression (TTP).
English: Sporadic dose related lameness, stiffness, weakness and pain in limbs resolved without treatment.
Danish: Sporadisk dosisrelateret halthed, stivhed, svaghed og smerter i benene ophørte uden behandling.
English: Canine mast cell tumour growth is frequently driven by an activating mutation in c-Kit.
Danish: Mastcelletumorvækst hos hunde er ofte drevet af en aktiverende mutation i c-Kit.
English: Two dogs (6 mg/kg) were euthanised at approximately 3 weeks for treatment-related clinical toxicities initiated by decreased feed intake and melena culminating in anorexia, weight loss and hematochezia.
Danish: To hunde (6 mg/kg) blev aflivet efter ca. 3 uger på grund af behandlingsrelateret klinisk toksicitet indledt med nedsat fødeindtagelse og melæna, som kulminerede i anoreksi, vægttab og hæmatokesi.
English: • Severe lameness/musculoskeletal disorder.
Danish: • Alvorlig halthed/muskuloskeletale forstyrrelser.
English: Overdosing signs were observed in a toxicity study conducted in healthy adult Beagle dogs treated with 2 mg/kg, 4 mg/kg or 6 mg toceranib/kg once every other day for 13 consecutive weeks without dose interruption.
Danish: Tegn på overdosering blev observeret i et toksicitetsstudie udført med raske voksne hunde af racen beagle behandlet med 2 mg/kg, 4 mg/kg eller 6 mg toceranib/kg én gang hver anden dag i 13 på hinanden følgende uger uden dosisafbrydelse.
English: In order to achieve correct dosing, tablets of different strengths (“colours”) might need to be combined as described in the table.
Danish: Det kan være nødvendigt at kombinere tabletter med forskellig styrke (”farver”) for at opnå den korrekte dosis, som beskrevet i doseringstabellen.
English: For any mast cell tumour treatable by surgery, surgery should be the first choice of treatment.
Danish: For enhver mastcelletumor, der kan behandles med operation, bør operation være første behandlingsvalg.
English: Palladia 10 mg: blue Palladia 15 mg: orange Palladia 50 mg: red
Danish: Palladia 10 mg: Blå Palladia 15 mg: Orange Palladia 50 mg: Rød
English: Toceranib induces cell cycle arrest and subsequent apoptosis in tumour cell lines expressing activating mutations in the split kinase RTK, c-Kit.
Danish: Toceranib inducerer cellecyklusstop og efterfølgende apoptose i tumorcellelinjer, hvilket er et udtryk for aktiverende mutationer i splitkinase RTK, c-Kit.
English: Toceranib selectively inhibits the tyrosine kinase activity of several members of the split kinase receptor tyrosine kinase (RTK) family some of which are implicated in tumour growth, pathologic angiogenesis, and metastatic progression of cancer.
Danish: Toceranib hæmmer selektivt tyrosinkinaseaktiviteten af flere medlemmer af splitkinase receptortyrosinkinase (RTK)-familien, hvoraf nogle er impliceret i tumorvækst, patologisk angiogenese og metastatisk progression af cancer.
English: Dose interruptions and dose reductions may be needed depending upon the severity of clinical signs.
Danish: Afbrydelse af behandling og dosisreduktion kan være nødvendig afhængigt af, hvor alvorlige de kliniske tegn er.
English: Wash hands thoroughly with soap and water following handling of the product, and disposing of vomit, urine, or faeces of treated dogs.
Danish: Vask hænderne grundigt med sæbe og vand efter håndtering af produktet og bortskaffelse af opkast, urin eller fæces fra behandlede hunde.
English: Toceranib inhibited the activity of Flk1/KDR tyrosine kinase (vascular endothelial growth factor receptor, VEGFR2), platelet-derived growth factor receptor (PDGFR) and stem cell factor receptor (c-Kit) in both biochemical and cellular assays.
Danish: Toceranib hæmmede aktiviteten af Flk1/KDR tyrosinkinase (vaskulær endotel-vækstfaktorreceptor, VEGFR2), trombocytderiveret vækstfaktorreceptor (PDGFR) og stamcellefaktorreceptor (c-Kit) i både biokemiske og cellulære analyser.
English: With a regimen of 3.25 mg toceranib/kg bodyweight administered by tablet orally every other day for 2 weeks (7 doses), the following pharmacokinetic parameters of toceranib in plasma in healthy Beagle dogs were reported: elimination half-life (t1/2) 17.2 ± 3.9 hours, time to maximum plasma concentration (Tmax) approximately 6.2 ± 2.6 hours, maximum plasma concentration (Cmax) approximately 108 ± 41 ng/ml, minimum plasma concentration (Cmin) 18.7 ± 8.3 ng/ml and the area under the plasma concentration time-curve (AUC0-48) 2640 ± 940 ng·h/ml.
Danish: Der blev rapporteret følgende farmakokinetiske parametre for toceranib i plasma hos raske beaglehunde ved et regime på 3,25 mg toceranib/kg legemsvægt, administreret peroralt som tabletter hver anden dag i 2 uger (7 doser): Eliminationshalveringstid (t1/2): 17,2 ± 3,9 timer, tid til maksimal plasmakoncentration (Tmax) cirka 6,2 ± 2,6 timer, maksimal plasmakoncentration (Cmax) cirka 108 ± 41 ng/ml, minimum plasmakoncentration (Cmin) 18.7 ± 8.3 ng/ml og areal under plasma-koncentrationstidskurven (AUC0-48) 2640 ± 940 ng·t/ml.
English: • Absolute neutrophil count >1500/microlitre
Danish: • Komplet neutrofiltælling >1500/mikroliter
English: Periodic monitoring of laboratory variables should be completed in the context of the clinical signs and condition of the animal and results of laboratory variables at prior visits.
Danish: Regelmæssig kontrol af laboratorievariabler bør udføres på baggrund af kliniske tegn, dyrets tilstand og blodprøveresultater ved tidligere konsultationer.
English: Results from the clinical field study involving 151 treated and placebo-treated dogs showed that the clinical signs of the disease (mast cell tumour) and treatment related adverse reactions are very similar in nature.
Danish: Resultater fra et klinisk feltstudie med 151 behandlede og placebobehandlede hunde viste, at kliniske tegn på sygdom (mastcelletumor) og behandlingsrelaterede bivirkninger er meget lignende i karakter.
English: Discontinue treatment until clinical signs and clinical pathology have normalised.
Danish: Behandlingen afbrydes, indtil kliniske tegn og klinisk patologi er normaliseret.
English: In the case of accidental ingestion, seek medical advice immediately and show Package Leaflet or label to the physician.
Danish: Søg straks lægehjælp ved utilsigtet indtagelse, og vis indlægssedlen eller etiketten til lægen.
English: The main target organs of toxicity include the gastrointestinal tract, bone marrow, gonads and musculoskeletal system.
Danish: De vigtigste målorganer for toksicitet omfatter mave-tarmkanal, knoglemarv, gonader og bevægeapparatet.
English: Treatment of non-resectable Patnaik grade II (intermediate grade) or III (high grade), recurrent, cutaneous mast cell tumours.
Danish: Behandling af ikke-resektabel Patnaik grad II (intermediær grad) eller III (høj grad), recidiverende, kutane mastcelletumorer.
English: Neutropenia (neutrophil count) >1000/ul
Danish: Neutropeni (neutrofiltælling) >1000/µl
English: ≥1.25 X upper normal limit
Danish: ≥1,25 X øvre normalgrænse
English: Treatment should be reviewed weekly for the first six weeks and every six weeks thereafter or at intervals deemed appropriate by the veterinarian.
Danish: Behandling bør evalueres ugentligt de første seks uger og hver 6. uge derefter, eller med intervaller, som dyrlægen vurderer, er passende.
English: Diarrhoea <4 watery stools/day for < 2 days or soft stools
Danish: Diarré <4 vandige afføringer/dag i <2 dage eller bløde afføringer
English: The tablets must be administered as a whole and should not be broken or ground.
Danish: Tabletterne skal administreres hele og bør ikke knækkes eller knuses.
English: Toceranib is metabolised in the liver and in the absence of any studies on the effects of renal or hepatic impairment, should be used with caution in dogs suffering from hepatic disease.
Danish: Toceranib metaboliseres i leveren, og på grund af manglende studier af virkning ved nedsat nyre- eller leverfunktion, bør anvendes med forsigtighed til hunde, der lider af leversygdomme.
English: Cardboard carton containing four Aluminium-PVC child resistant blister packs.
Danish: Æske med fire aluminium-PVC børnesikrede blisterpakninger.
English: Anaemia (hematocrit)
Danish: Anæmi (hæmatokrit)
English: In rare cases, serious and sometimes fatal gastrointestinal complications including gastrointestinal perforation have occurred in dogs treated with Palladia.
Danish: Der er i sjældne tilfælde forekommet alvorlige og nogle gange fatale gastrointestinale komplikationer, herunder gastrointestinal perforation hos hunde behandlet med Palladia (se pkt.
English: If you notice any side effects, even those not already listed in this package leaflet or you think that the medicine has not worked, please inform your veterinary surgeon.
Danish: Dette gælder også bivirkninger, der ikke allerede er anført i denne indlægsseddel eller hvis du mener, at dette lægemiddel ikker har virket efter anbefalingerne.
English: MARKETING AUTHORISATION NUMBER(S) EU/2/09/100/001
Danish: MARKEDSFØRINGSTILLADELSENS NUMMER (NUMRE) EU/2/09/100/001
English: Other compounds in the anti-angiogenic class of anti-neoplastic agents are known to increase embryolethality and foetal abnormalities.
Danish: Det er kendt, at andre substanser i den anti-angiogene gruppe af antineoplastiske lægemidler øger embryoletaliteten og føtale anomalier.
English: Treatment should be permanently discontinued if severe adverse events recur or persist, despite appropriate supportive care and dose reduction.
Danish: Behandlingen bør afbrydes permanent, hvis alvorlige bivirkninger vender tilbage eller varer ved på trods af passende understøttende behandling og nedsættelse af dosis.
English: To manage adverse reactions, the dose may be reduced to 2.75 mg/kg bodyweight or further to 2.25 mg/kg bodyweight administered every second day or treatment can be discontinued for up to two weeks (see Dose Adjustment table in section 4.5).
Danish: For at kontrollere bivirkningerne kan dosis reduceres til 2,75 mg/kg legemsvægt eller yderligere til 2,25 mg/kg legemsvægt administreret hver 2. dag, eller behandlingen kan seponeres i op til to uger (se tabel for dosisjustering i pkt.
English: Toceranib was well tolerated at 2 mg/kg dose level whereas adverse reactions were noted in some dogs treated with 4 mg/kg and thus a NOAEL could not be established.
Danish: Toceranib var veltålt ved 2 mg/kg, hvorimod der blev observeret bivirkninger hos nogle hunde behandlet med 4 mg/kg, og derfor kan NOAEL (No Observed Adverse Effect Level) ikke fastslås.
English: • Platelet count >75,000/microlitre
Danish: • Blodpladetælling >75.000/mikroliter
English: Treatment should be permanently discontinued if severe adverse events recur or persist despite appropriate supportive care and dose reduction as described in the following table.
Danish: Behandlingen bør afbrydes permanent, hvis der opstår recidiv af alvorlige bivirkninger, eller de er vedvarende på trods af passende understøttende behandling og reduceret dosis, som beskrevet i den følgende tabel.
English: Hepatic Toxicity (ALT, AST) >1X - 3X upper normal limit
Danish: Hepatotoksicitet (ALAT, ASAT) >1X - 3X øvre normalgrænse
English: PHARMACEUTICAL FORM Film-coated tablets.
Danish: LÆGEMIDDELFORM Filmovertrukne tabletter.
English: If a broken tablet is rejected by the dog after chewing, it should be disposed of.
Danish: Hvis en hund ikke synker en knækket tablet, efter den er tygget, skal tabletten bortskaffes.
English: Each tablet also contains lactose monohydrate, cellulose microcrystalline, magnesium stearate, silica colloidal anhydrous and Crospovidone.
Danish: Hver tablet indeholder også lactosemonohydrat, mikrokrystallinsk cellulose, magnesiumstearat, kolloid vandfri silica og crospovidon.
English: In one dog, pathology findings revealed vascular thrombosis with disseminated intravascular coagulopathy (DIC) and pancreatitis.
Danish: Patologiske fund viste vaskulær trombose med dissemineret intravaskulær koagulation (DIC) og pankreatitis hos én hund.
English: Do not use in dogs less than 2 years of age or less than 3 kg body weight.
Danish: Bør ikke anvendes til hunde der er yngre end 2 år eller med legemsvægt under 3 kg.
English: Lactose monohydrate Cellulose, microcrystalline Magnesium stearate Silica, colloidal anhydrous Crospovidone
Danish: Lactosemonohydrat Mikrokrystallinsk cellulose Magnesiumstearat Silica, kolloid vandfri Crospovidon
English: Do not use in case of hypersensitivity to the active substance or to any of the other ingredients of Palladia.
Danish: Bør ikke anvendes i tilfælde af overfølsomhed over for de aktive stof eller over for et eller flere af hjælpestofferne i Palladia.
English: >3X upper normal limit
Danish: >3X øvre normalgrænse
English: Gastrointestinal Bleeding Fresh blood in stool or black tarry stool for >2 days or frank haemorrhage or blood clots in stool
Danish: Gastrointestinal blødning Frisk blod i afføring eller sort tjærelignende afføring > 2 dage eller synlig blødning eller koagler i afføring
English: The tablets must be administered as a whole and should not be divided, broken or ground.
Danish: Tabletterne skal gives hele, og må ikke deles, knækkes eller knuses.
English: Dose reductions and/or dose interruptions may be needed to manage adverse events.
Danish: Dosisreduktioner og/eller afbrydelse af behandling kan være nødvendig for at kontrollere bivirkninger.
English: The following handling procedures will help to minimise exposure to the active ingredient in Palladia for you and other members of your household:
Danish: Følgende fremgangsmåde kan medvirke til, at du og andre i din husstand er mindre udsatte for kontakt med det aktive stof i Palladia:
English: The following adverse events were uncommon (more than 1 but less than 10 animals in 1,000 treated):
Danish: De følgende bivirkninger var ikke almindelige (flere end 1, men færre end 10 dyr af 1.000 behandlede dyr):
English: Discontinue treatment and institute dietary modification ± supportive care until food intake improves, then decrease dose by 0.5 mg/kg
Danish: Afbryd behandling og iværksæt kostomlægning ± understøttende behandling indtil fødeindtagelsen forbedres, nedsæt derefter dosis med 0,5 mg/kg.
English: Another dog developed epistaxis with concurrent disseminated intravascular coagulopathy.
Danish: En anden hund udviklede epistaksis med samtidig dissemineret intravaskulær koagulationsdefekt.
English: Very common (more than 1 in 10 animals treated displaying adverse reaction(s))
Danish: Meget almindelig (flere end 1 ud af 10 behandlede dyr, der viser bivirkninger i løbet af en behandling)
English: • If you are pregnant, you should not routinely administer Palladia; however, if you choose to give these tablets to your dog, you should be particularly careful and follow the handling procedures described below.
Danish: Hvis du imidlertid vælger at give disse tabletter til din hund, bør du være særligt forsigtig og følge fremgangsmåden beskrevet nedenfor.
English: • Severe circulatory shock.
Danish: • Alvorligt kredsløbsshock.
English: DOSING TABLE: PALLADIA TABLETS:- 3.25 mg/kg BODYWEIGHT
Danish: DOSERINGSTABEL: PALLADIA TABLETTER: 3,25 mg/kg LEGEMSVÆGT
English: Each film-coated tablet contains toceranib phosphate equivalent to 10 mg, 15 mg or 50 mg of toceranib as active substance.
Danish: Hver filmovertrukket tablet indeholder toceranibphosphat svarende til 10 mg, 15 mg eller 50 mg toceranib som aktivt stof.
English: • Bilirubin <1.25 X upper normal limit
Danish: • Bilirubin <1,25 gange øvre normalgrænse
English: Palladia film-coated tablets are available in 10 mg, 15 mg and 50 mg strength.
Danish: Palladia filmovertrukne tabletter fås i 10 mg, 15 mg og 50 mg.
English: Dose Adjustment*
Danish: Dosisjustering*
English: EU/2/09/100/002 (15 mg tablets)
Danish: EU/2/09/100/002 (15 mg tabletter)
English: EU/2/09/100/003 (50 mg tablets)
Danish: EU/2/09/100/003 (50 mg tabletter)
English: Do not use in case of hypersensitivity to the active substance or to any of the excipients.
Danish: Bør ikke anvendes i tilfælde af overfølsomhed over for de aktive stof eller over for et eller flere af hjælpestofferne.
English: Common (more than 1 but less than 10 animals in 100 animals treated)
Danish: Almindelige (flere end 1, men færre end 10 dyr af 100 behandlede dyr)
English: Do not use in pregnant or lactating bitches or in dogs intended for breeding (see section 5).
Danish: Må ikke anvendes til drægtige eller diegivende tæver eller til hunde, som skal anvendes til avl (se pkt.
English: In cases of accidental ingestion of Palladia, you may experience stomach discomfort, including vomiting or diarrhoea.
Danish: Hvis Palladia indtages ved et uheld, kan du få maveproblemer, herunder opkastning og diarré.
English: MARKETING AUTHORISATION NUMBER(S) EU/2/09/100/001 (10 mg tablets)
Danish: MARKEDSFØRINGSTILLADELSENS NUMMER (NUMRE) EU/2/09/100/001 (10 mg tabletter)
English: The initial recommended dose is 3.25 mg/kg bodyweight, administered every second day (see Dosing table for details).
Danish: Den anbefalede startdosis er 3,25 mg toceranib/kg legemsvægt administreret hver anden dag (se doseringstabel vedrørende detaljer).
English: • Severe circulatory shock
Danish: • Alvorligt kredsløbsshock
English: * the number of tablets required for dogs below 5.0 kg or above 63 kg bodyweight, should be calculated based on the 3.25 mg/kg dosage regime.
Danish: * Antallet af tabletter til hunde under 5,0 kg eller over 63 kg legemsvægt, bør beregnes ud fra doseringsvejledningen for 3,25 mg/kg.
English: The initial dose is approximately 3.25 mg/kg bodyweight, given every second day (see dosing table for details).
Danish: Startdosis er cirka 3,25 mg toceranib/kg legemsvægt, givet hver anden dag (se doseringstabellen vedrørende nærmere oplysninger).
English: Do not use in pregnant or lactating bitches or in dogs intended for breeding.
Danish: Bør ikke anvendes til drægtige eller diegivende tæver eller til hunde, som skal anvendes til avl.
English: * The number of tablets required for dogs below 5.0 kg or above 63 kg bodyweight, should be calculated based on the 3.25 mg/kg dosage regime.
Danish: * Antallet af tabletter til hunde med en legemsvægt under 5,0 kg eller over 63 kg, bør beregnes ud fra doseringsvejledningen for 3,25 mg/kg.
English: Avoid skin contact with the tablets, faeces, urine, and vomit of treated dogs.
Danish: Undgå hudkontakt med tabletter, fæces, urin og opkast fra behandlede hunde.
English: • Localised or general pain, nausea, tachypnea, polydipsia, flatulence, pyrexia, nasal depigmentation; changes in coat colour, alopecia, urinary tract infection; increased bilirubin, increased creatinine.
Danish: • Lokaliseret eller generaliseret smerte, kvalme, takypnø, polydipsi, flatulens, pyreksi, nasal depigmentering; ændret pelsfarve, alopeci, urinvejsinfektion; øget bilirubin, øget kreatinin.
English: Do not break or grind the tablets.
Danish: • Når du håndterer tabletterne: √ Del eller knæk ikke tabletterne.
English: Renal Toxicity (creatinine) <1.25 X upper normal limit
Danish: Nephrotoksicitet (kreatinin) <1,25 X øvre normalgrænse
English: Macrogol, Titanium dioxide (E171), Lactose monohydrate, Triacetin, Hypromellose, Sunset Yellow Lake (E110), Iron oxide red (E172)
Danish: Macrogol, titandioxid (E171), lactosemonohydrat, triacetin, hypromellose, Sunset Yellow Lake (E110), rød jernoxid (E172)
English: Do not use in dogs with evidence of stomach bleeding.
Danish: Bør ikke anvendes til hunde med maveblødning.
English: Each film-coated tablet contains toceranib phosphate equivalent to 10 mg, 15 mg or 50 mg of toceranib.
Danish: Hver filmovertrukket tablet indeholder toceranibphosphat svarende til 10 mg, 15 mg eller 50 mg toceranib.
English: • ALT or AST <3 X upper normal limit
Danish: • ALAT eller ASAT <3 gange øvre normalgrænse
English: Uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
Danish: Ikke almindelige (flere end 1, men færre end 10 dyr af 1.000 behandlede dyr)
English: DOSING TABLE: PALLADIA TABLETS AT 3.25 MG/KG BODYWEIGHT
Danish: DOSERINGSTABEL: PALLADIA TABLETTER VED 3,25 MG/KG LEGEMSVÆGT Hundens legemsvægt (kg)
English: Macrogol, Titanium dioxide (E171), Lactose monohydrate, Triacetin, Hypromellose, Talc, Iron oxide red (E172)
Danish: Macrogol, titandioxid (E171), lactosemonohydrat, triacetin, hypromellose, talcum, rød jernoxid (E172)
English: If more than the prescribed amount of tablets were given, contact your veterinarian.
Danish: Kontakt din dyrlæge, hvis der er givet flere tabletter end der er ordineret.
English: Palladia 15 mg tablets:
Danish: Palladia 15 mg tabletter:
English: Palladia 50 mg tablets:
Danish: Palladia 50 mg tabletter: